EB Pharma Developments
Details
Company details
- Enterprise number
- 0780.755.671
- VAT number
- BE 0780.755.671
- Peppol ID
- 0208:0780755671
- Legal form
- Besloten Vennootschap
- Start date
- 21/01/20224 years
- Main activity
- Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg 74999
3570 Alken
Why
Is EB Pharma Developments a healthy company?
Return on equityWeak
The company makes little profit on the money its owners put in.
−25.4%. Typical in the sector: 12.3%
Debt service coverageWeak
What the company earns in a year barely covers that year's loan repayments, or falls short.
−12.97×
Return on assetsWeak
The company makes little profit from everything it owns.
−7.2%. Typical in the sector: 6.2%
Based on the 2025 annual accounts, filed on 25/03/2026. View the annual accounts at the NBB
Creya method: information, not advice. How we calculate
Sector comparison
How does EB Pharma Developments compare with its sector?
We set every ratio against similar companies, using the National Bank's sector figures.
Compare with the sectorKey figures
Figures over the years
- Gross margin 2025
- −€1,127
- −130%
- Profit or loss 2025
- −€1,347
- −138%
- Equity 2025
- €5,298
- −68%
- Employees (FTE) 2025
- Not published
Tap a row to see its chart
Hover a row to see its chart
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Gross margin | −€1,127−130% | €3,749Rose | −€4,297−120% | €20,964 |
| Operating result | −€1,589−148% | €3,300Rose | −€4,744−123% | €20,616 |
| Profit or loss | −€1,347−138% | €3,567Rose | −€4,644−129% | €16,222 |
| Balance sheet | ||||
| Equity | €5,298−68% | €16,645+27% | €13,078−26% | €17,722 |
| Total assets | €16,951−11% | €19,064+46% | €13,078−41% | €22,037 |
| Filed | 25/03/2026 | 25/07/2025 | 30/07/2024 | In 2023 |
Amounts as filed with the National Bank. Small companies don't have to publish their revenue. 2022: previous fiscal year, as stated in the 2023 annual accounts.
Management
Who runs EB Pharma Developments?
According to the annual accounts of 25/03/2026.
Directors (1)
- ERIK BUNTINXDirectorsince 19/01/2022
Credit limit
Know how much credit you can safely give this company, before you invoice.
Timeline
Filed annual accounts
Questions
Frequently asked questions about EB Pharma Developments
Is EB Pharma Developments a healthy company?
At risk. The latest annual accounts show serious weak points. Based on the 2025 annual accounts, filed on 25/03/2026.
What is the revenue of EB Pharma Developments?
EB Pharma Developments doesn't have to publish its revenue. The gross margin was −€1,127 in 2025.
How much profit does EB Pharma Developments make?
The result of fiscal year 2025 was −€1,347.
Who manages EB Pharma Developments?
According to the annual accounts of 25/03/2026: ERIK BUNTINX.
What is the VAT number of EB Pharma Developments?
The VAT number is BE 0780.755.671. The enterprise number is 0780.755.671.
Where is EB Pharma Developments located?
Alkerstraat 28, 3570 Alken.
What is the Peppol ID of EB Pharma Developments?
The Peppol ID is 0208:0780755671.
When was EB Pharma Developments founded?
The start date in the KBO is 21/01/2022.
Sources
Where do these numbers come from?
- National Bank of BelgiumAnnual accounts · latest filed on 25/03/2026
- Crossroads Bank for EnterprisesCompany details · address, legal form, activity
- Peppol DirectoryPeppol ID · e-invoicing
- Verdict
- Key figures
- Sector comparison
Something not right?